Stock Market

JPMorgan Boosts Edgewise Therapeutics PT to $45 Amid Pipeline Optimism

By Bullbit Editorial · March 30, 2026

• WhatJPMorgan raised Edgewise Therapeutics' price target to $45
• WhyOptimism surrounds EDG-7500 pipeline developments
• SignalStrong pipeline growth indicates company's potential
• TargetInvestors focus on Edgewise Therapeutics' pipeline progress
• RiskMarket volatility may impact Edgewise Therapeutics' stock value

More breaking news →